Command Palette

Search for a command to run...

Clinical Trials · NCT02655770

Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Rigshospitalet, Denmark
Enrollment
40
Start date
Feb 2016
Locations
1 site, Denmark
Primary endpoint
Change in diastolic properties as assessed by CMR.
View Liraglutide compound reference